Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Rachel K. Toth; Noel A. Warfel

doi:10.1158/1535-7163.MCT-20-0535

AACR Journals

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Journals

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Review

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Rachel K. Toth and Noel A. Warfel

Rachel K. Toth

1University of Arizona Cancer Center, Tucson, Arizona.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Noel A. Warfel

1University of Arizona Cancer Center, Tucson, Arizona.

2Department of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: warfelna@arizona.edu

DOI: 10.1158/1535-7163.MCT-20-0535 Published January 2021

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

January 2021
Volume 20, Issue 1

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Message Subject (Your Name) has forwarded a page to you from Molecular Cancer Therapeutics

Message Body (Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Rachel K. Toth and Noel A. Warfel

Mol Cancer Ther January 1 2021 (20) (1) 3-10; DOI: 10.1158/1535-7163.MCT-20-0535

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Rachel K. Toth and Noel A. Warfel

Mol Cancer Ther January 1 2021 (20) (1) 3-10; DOI: 10.1158/1535-7163.MCT-20-0535

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Articles

Online First
Current Issue
Past Issues
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About MCT

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Main menu

User menu

Search

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Purchase access

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About MCT